SPE2D2-22-D-0140 P00008 to exercise Option Year 4 effective December 08, 2025 through December 07, 2026. SPE2D2-22-D-0140 P00007 is modified in accordance with DoD Class Deviation 2025-O0003. SPE2D2-22-D-0140 P00006 to exercise Option Year 3 effective December 08, 2024 through December 07, 2025. SPE2D2-22-D-0140 P00005 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024. SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract. SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract. Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140 Contract Award for Furosemide Tablets SPE2D222D0140